Killer Immunoglobulin-Like Receptor Profiles Are not Associated with Risk of Amoxicillin-Clavulanate-Induced Liver Injury in Spanish Patients.

Camilla Stephens, Antonia Moreno-Casares, Miguel-Ángel López-Nevot, Miren García-Cortés, Inmaculada Medina-Cáliz, Hacibe Hallal, German Soriano, Eva Roman, Francisco Ruiz-Cabello, Manuel Romero-Gomez, M Isabel Lucena, Raúl J Andrade
Author Information
  1. Camilla Stephens: Unidad de Gestión Clínica de Aparato Digestivo, Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd Málaga, Spain.
  2. Antonia Moreno-Casares: Unidad de Gestión Clínica de Laboratorio, Departamento de Bioquímica y Biología Molecular III/Inmunología, Instituto de Investigación Biosanitario de Granada, Complejo Hospitalario de Granada, Universidad de Granada Granada, Spain.
  3. Miguel-Ángel López-Nevot: Unidad de Gestión Clínica de Laboratorio, Departamento de Bioquímica y Biología Molecular III/Inmunología, Instituto de Investigación Biosanitario de Granada, Complejo Hospitalario de Granada, Universidad de Granada Granada, Spain.
  4. Miren García-Cortés: Unidad de Gestión Clínica de Aparato Digestivo, Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd Málaga, Spain.
  5. Inmaculada Medina-Cáliz: Unidad de Gestión Clínica de Aparato Digestivo, Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd Málaga, Spain.
  6. Hacibe Hallal: Servicio de Aparato Digestivo, Hospital Morales Meseguer Murcia, Spain.
  7. German Soriano: Servicio de Gastroenterología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, CIBERehd Barcelona, Spain.
  8. Eva Roman: Servicio de Gastroenterología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, CIBERehdBarcelona, Spain; Escola Universitària d'Infermeria-Sant Pau, Universitat Autònoma de BarcelonaBarcelona, Spain.
  9. Francisco Ruiz-Cabello: Servicio de Aparato Digestivo, Hospital Morales Meseguer Murcia, Spain.
  10. Manuel Romero-Gomez: Unidad de Gestión Clínica de Aparato Digestivo Intercentros, Hospitales Universitarios Virgen Macarena-Virgen del Rocio, CIBERehd Seville, Spain.
  11. M Isabel Lucena: Unidad de Gestión Clínica de Aparato Digestivo, Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd Málaga, Spain.
  12. Raúl J Andrade: Unidad de Gestión Clínica de Aparato Digestivo, Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd Málaga, Spain.

Abstract

Natural killer cells are an integral part of the immune system and represent a large proportion of the lymphocyte population in the liver. The activity of these cells is regulated by various cell surface receptors, such as killer Ig-like receptors (KIR) that bind to human leukocyte antigen (HLA) class I ligands on the target cell. The composition of KIR receptors has been suggested to influence the development of specific diseases, in particularly autoimmune diseases, cancer and reproductive diseases. The role played in idiosyncratic drug-induced liver injury (DILI) is currently unknown. In this study, we examined KIR gene profiles and HLA class I polymorphisms in amoxicillin-clavulanate (AC) DILI patients in search for potential risk associations. One hundred and two AC DILI patients and 226 controls were genotyped for the presence or absence of 16 KIR loci, including the two pseudogenes 2DP1 and 3DP1. No significant differences were found in the distribution of individual KIRs between patients and controls, which were comparable to previously reported KIR data from ethnically similar cohorts. The 21.6 and 21.2% of the patients and controls, respectively, were homozygous haplotype A carriers, while 78.4 and 78.8%, respectively, contained at least one B haplotype (Bx). The genotypes translated into 27 (AC DILI) and 46 (controls) different gene profiles, with 19 being present in both groups. The most frequent Bx gene profile containing KIRs 2DS2, 2DL2, 2DL3, 2DP1, 2DL1, 3DL1, 2DS4, 3DL2, 3DL3, 2DL4, and 3PD1 was present in 16% of the DILI patients and 14% of the controls. The distribution of HLA class I epitopes did not differ significantly between AC DILI patients and controls. The most frequent receptor-ligand combinations in the DILI patients were 2DL3 + epitope C1 (67%) and 3DL1 + Bw4 motif (67%), while 2DL1 + epitope C2 (69%) and 3DL1 + Bw4 motif (69%) predominated in the controls. This is to our knowledge the first analysis of KIR receptor-HLA ligand associations in DILI, although our findings do not support evidence of these genetic variations playing a major role in AC DILI development.

Keywords

References

  1. Immunity. 1997 Dec;7(6):753-63 [PMID: 9430221]
  2. Mol Immunol. 2014 Jan;57(1):52-8 [PMID: 23910730]
  3. Mol Immunol. 2011 Sep;48(15-16):1896-902 [PMID: 21665278]
  4. Gastroenterology. 2011 Jul;141(1):338-47 [PMID: 21570397]
  5. Clin Pharmacol Ther. 2011 Jun;89(6):806-15 [PMID: 21544079]
  6. Gastroenterology. 2014 Jul;147(1):109-118.e5 [PMID: 24704526]
  7. Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):395-409 [PMID: 25491399]
  8. PLoS One. 2012;7(7):e39991 [PMID: 22768326]
  9. Hepatology. 2013 Apr;57(4):1654-62 [PMID: 23111952]
  10. Eur J Immunol. 2005 Jan;35(1):10-5 [PMID: 15580655]
  11. J Immunol. 1997 May 1;158(9):4026-8 [PMID: 9126959]
  12. PLoS Med. 2011 Sep;8(9):e1001092 [PMID: 21931540]
  13. PLoS One. 2016 Jan 08;11(1):e0146086 [PMID: 26744892]
  14. Lupus. 2010 Jan;19(1):20-6 [PMID: 19926642]
  15. J Immunol. 1997 Jun 1;158(11):5237-41 [PMID: 9164941]
  16. Blood. 2008 Aug 1;112(3):708-10 [PMID: 18502829]
  17. Hum Immunol. 2010 Feb;71(2):192-4 [PMID: 19897003]
  18. Immunogenetics. 2012 Oct;64(10):719-37 [PMID: 22752190]
  19. Hepatology. 2006 Feb;43(2):362-72 [PMID: 16440347]
  20. Endocrine. 2014 Aug;46(3):519-25 [PMID: 24174177]
  21. J Biol Chem. 2015 Apr 17;290(16):10460-71 [PMID: 25759384]
  22. Eur J Immunol. 2004 Jun;34(6):1673-9 [PMID: 15162437]
  23. Hepatology. 2005 Aug;42(2):481-9 [PMID: 16025496]
  24. Gastroenterology. 2005 Aug;129(2):512-21 [PMID: 16083708]
  25. Clin Cancer Res. 2013 Oct 1;19(19):5465-73 [PMID: 23938290]
  26. Tissue Antigens. 2010 Jul;76(1):9-17 [PMID: 20331834]
  27. PLoS One. 2013 Jul 09;8(7):e68111 [PMID: 23874514]
  28. Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13224-9 [PMID: 16141329]
  29. Nucleic Acids Res. 2005 Jan 1;33(Database issue):D523-6 [PMID: 15608253]
  30. J Immunol. 2008 Mar 15;180(6):3969-79 [PMID: 18322206]
  31. J Immunol. 2013 Jun 15;190(12):6198-208 [PMID: 23686481]
  32. J Hepatol. 2007 May;46(5):899-906 [PMID: 17383044]

Word Cloud

Created with Highcharts 10.0.0DILIpatientscontrolsKIRACHLA+liverreceptorsclassdiseasesgene3DL1killercellsimmunecelldevelopmentroledrug-inducedinjuryprofilesassociationstwo2DP1distributionKIRs21respectivelyhaplotype78Bxpresentfrequent2DL32DL1epitope67%Bw4motif69%NaturalintegralpartsystemrepresentlargeproportionlymphocytepopulationactivityregulatedvarioussurfaceIg-likebindhumanleukocyteantigenligandstargetcompositionsuggestedinfluencespecificparticularlyautoimmunecancerreproductiveplayedidiosyncraticcurrentlyunknownstudyexaminedpolymorphismsamoxicillin-clavulanatesearchpotentialriskOnehundred226genotypedpresenceabsence16lociincludingpseudogenes3DP1significantdifferencesfoundindividualcomparablepreviouslyreporteddataethnicallysimilarcohorts62%homozygouscarriers48%containedleastoneBgenotypestranslated2746different19groupsprofilecontaining2DS22DL22DS43DL23DL32DL43PD116%14%epitopesdiffersignificantlyreceptor-ligandcombinationsC1C2predominatedknowledgefirstanalysisreceptor-HLAligandalthoughfindingssupportevidencegeneticvariationsplayingmajorKillerImmunoglobulin-LikeReceptorProfilesAssociatedRiskAmoxicillin-Clavulanate-InducedLiverInjurySpanishPatientshepatotoxicityresponsepharmacogeneticsreceptor/ligand

Similar Articles

Cited By